Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
News

Synexus expands

July 30, 2009 Research and Development CRO, Synexus

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …
News

Contract research news in brief

July 28, 2009 Research and Development CRO

The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
News

Pharma and diagnostics to converge in personalised medicines

July 28, 2009 Research and Development, Sales and Marketing Diagnostics, strategy

News
Toronto skyline

Canada’s biotech challenge

July 27, 2009 Research and Development Canada, Transition Therapeutics, biotech, funding

 The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
Feature

Sanofi buys Indian vaccines firm

July 27, 2009 Research and Development, Sales and Marketing Asia, Sanofi-Aventis, vaccines

News

AAIPharma sells development services unit

July 27, 2009 Manufacturing and Production, Research and Development AAI Pharma

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …
News

BMS buys Medarex for $2.1 billion

July 24, 2009 Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
News

Lupus drug shows surprise phase III success

July 23, 2009 Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
News

Effient ‘unlikely’ to takeover from Plavix

July 23, 2009 Research and Development, Sales and Marketing Effient, cv

News

Kennedy calls for overhaul of NICE processes

July 23, 2009 Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
News

NICE approves MabThera for leukaemia

July 22, 2009 Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
News

Phase Forward buys Covance unit for $10m

July 21, 2009 Research and Development CRO, Phase Forward

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009 Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
News

Jubilant makes solid start to fiscal 2010

July 20, 2009 Manufacturing and Production, Research and Development Jubilant

Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026